
The ABPI has expressed concerns over the remit of NICE International and its affect on global markets. NICE International is …

The head of NICE says pharma will face health technology assessment barriers in every country – including fast-growing developing markets. …
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion

